News Powered By:
- a collaborative partner.
CenterWatch News Online Headlines : October 24, 2014 8:10 am : Centerwatch
Eli Lilly and Zymeworks, a Vancouver-based, privately held biotherapeutics company, are expanding an existing licensing and collaboration agreement. Originally announced in January, the global strategic collaboration is focused on the development of an undisclosed number of novel bi-specific antibody therapeutics using Zymeworks’ proprietary Azymetric platform.
CenterWatch News Online Headlines : October 24, 2014 8:09 am : Centerwatch
Sutro Biopharma, located in South San Francisco, has entered into a strategic collaboration and option agreement with Celgene to discover and develop multispecific antibodies and antibody drug conjugates (ADCs). This new agreement follows the December 2012 collaboration between the two companies and focuses on the field of immuno-oncology, while further broadening the Sutro platform for discovery, development and manufacture of best-in-class biotherapeutics.
CenterWatch News Online Headlines : October 24, 2014 8:07 am : Centerwatch
Johnson & Johnson Innovation plans to expand J-Labs (formerly Janssen Labs) to include a new incubator located within Texas Medical Center’s new Innovation Institute. The 30,000-square-foot J-Labs facility will accommodate up to 50 life science startups.
CenterWatch News Online Headlines : October 24, 2014 7:48 am : Centerwatch
Auxilium Pharmaceuticals has announced that the FDA has approved a supplemental Biologics Application (sBLA) for Xiaflex (collagenase clostridium histolyticum or CCH) for the treatment of up to two Dupuytren’s contracture (DC) joints in the same hand during a single treatment visit.
Treasury’s tax inversion changes scuttle some big biopharma mergers, modify others, prompting calls for Congressional corporate tax reform
CenterWatch News Online Headlines : October 23, 2014 10:50 am : Centerwatch
The widely-discussed $54.6 billion acquisition of Dublin-based Shire by AbbVie is officially canceled, having crumbled after a notice by the U.S. Treasury Department to tighten tax rules that deter U.S. companies from moving their legal headquarters to countries with lower business taxes.